Medtronic Financials - Benzinga

Medtronic PLC

MDTNYSE

Trade with Public

Trade with Public

$89.50

0.860.97%

가까이에: Sep 25, 5:00 PM EST

$89.21

0.570.64%

프리마켓: 6:27 AM EST

배당금: 배당락일은 4일 전이었습니다

개요 뉴스 실적 전망 이벤트 목표가재무심리 지분 현황 배당금 비교 옵션 주식 보고서

Medtronic Financials

Medtronic (MDT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Medtronic Posts Q1 Beat, 2027 Outlook Raise Validates Growth Inflection

MDT shares rise after Q1 beat and raised FY27 growth guidance. Analysts maintain Buy/Outperform ratings, citing broad-based strength.

Priya Nigam

Medtronic Analysts Raise Their Forecasts After Upbeat Q1 Earnings

Medtronic (NYSE:MDT) reported better-than-expected results and raised its FY27 EPS guidance. Analysts are bullish with raised price targets.

Avi Kapoor

Dow Dips Over 400 Points As Crude Oil Surges: Investor Sentiment Weakens Further, Fear & Greed Index Moves To ‘Fear’ Zone

The CNN Business Fear & Greed Index tracks market sentiment, with Tuesday's reading moving to Fear zone as stocks fell on rising yields and fears of Fed rate hikes.

Avi Kapoor

Medtronic Unleashes $780 Million Deal Spree After Strong Quarter

Medtronic (NYSE: MDT) stock rose after beating Q1 estimates and raising its FY27 forecast on strong cardiovascular sales.

Vandana Singh

PRO
Conference Call: Medtronic Sees Q2 Adj EPS $1.32-$1.34 vs $1.34 Est

Medtronic (NYSE:MDT) is looking for Q2 Adj EPS of $1.32-$1.34 vs $1.34 analyst estimate..

Benzinga Newsdesk

PRO
Medtronic Raises FY2027 Adj EPS Guidance from $5.90-$6.00 to $5.94-$6.00 vs $5.95 Est

Medtronic (NYSE:MDT) raises FY2027 Adj EPS guidance from $5.90-$6.00 to $5.94-$6.00 vs $5.95 analyst estimate..

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved